Table 1

Comparison of baseline characteristics between participants included in this follow-up study and those who refused, were lost to follow-up, or deceased

Follow-upRefused/lost to follow-up/deceased
Male/female, n203/24972/72
Spouse/unaffected relative/FCHL, n (%)113/244/95 (25/54/21)40/77/27 (28/53/19)
Age, years43±1351±17*
Smoking, n (%)136 (30)42 (29)
BMI, kg/m²25.7±4.026.5±4.6*
Waist circumference, cm91.0±12.294.7±13.8*
Total cholesterol, mmol/L5.6±1.35.8±1.4
HDL cholesterol, mmol/L1.0±0.21.0±0.3
LDL cholesterol, mmol/L3.9±1.24.1±1.3
Triglycerides, mmol/L1.3 (0.9–1.9)1.4 (1.0–2.0)
Apolipoprotein B, g/L1.1±0.31.1±0.3
Lipid lowering medication, n (%)71 (16)30 (22)
Systolic BP, mm Hg132±19140±25*
Diastolic BP, mm Hg84±1186±13
Anti-hypertensive medication, n (%)53 (12)39 (27)*
Glucose, mmol/L4.9 (4.6–5.3)5.1 (4.7–5.5)*
  • Data are expressed as mean ± SD or as medians with IQR between parentheses.

  • *P<0.05, analysed with a Student’s T-test, Mann-Whitney U test, and χ2 test in case of normally distributed, non-normally distributed, and dichotomous variables, respectively.

  • BMI, body mass index; BP, blood pressure; FCHL, familial combined hyperlipidemia; HDL, high-density lipoprotein; LDL, low-density lipoprotein.